Cargando…

Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens

In synovial cells of patients with osteoarthritis (OA) and rheumatoid arthritis (RA), conversion products of major anti-inflammatory androgens are as yet unknown but may be proinflammatory. Therefore, therapy with androgens in RA could be a problem. This study was carried out in order to compare con...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Martin, Weidler, Claudia, Naumann, Heidrun, Anders, Sven, Schölmerich, Jürgen, Straub, Rainer H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257423/
https://www.ncbi.nlm.nih.gov/pubmed/16207335
http://dx.doi.org/10.1186/ar1769
_version_ 1782125801922101248
author Schmidt, Martin
Weidler, Claudia
Naumann, Heidrun
Anders, Sven
Schölmerich, Jürgen
Straub, Rainer H
author_facet Schmidt, Martin
Weidler, Claudia
Naumann, Heidrun
Anders, Sven
Schölmerich, Jürgen
Straub, Rainer H
author_sort Schmidt, Martin
collection PubMed
description In synovial cells of patients with osteoarthritis (OA) and rheumatoid arthritis (RA), conversion products of major anti-inflammatory androgens are as yet unknown but may be proinflammatory. Therefore, therapy with androgens in RA could be a problem. This study was carried out in order to compare conversion products of androgens in RA and OA synoviocytes. In 26 OA and 24 RA patients, androgen conversion in synovial cells was investigated using radiolabeled substrates and analysis by thin-layer chromatography and HPLC. Aromatase expression was studied by immunohistochemistry. Dehydroepiandrosterone (DHEA) was converted into androstenediol, androstenedione (ASD), 16αOH-DHEA, 7αOH-DHEA, testosterone, estrone (E1), estradiol (E2), estriol (E3), and 16αOH-testosterone (similar in OA and RA). Surprisingly, levels of E2, E3, and 16α-hydroxylated steroids were as high as levels of testosterone. In RA and OA, 5α-dihydrotestosterone increased conversion of DHEA into testosterone but not into estrogens. The second androgen, ASD, was converted into 5α-dihydro-ASD, testosterone, and negligible amounts of E1, E2, E3, or 16αOH-testosterone. 5α-dihydro-ASD levels were higher in RA than OA. The third androgen, testosterone, was converted into ASD, 5α-dihydro-ASD, 5α-dihydrotestosterone, and negligible quantities of E1 and E2. 5α-dihydrotestosterone was higher in RA than OA. ASD and testosterone nearly completely blocked aromatization of androgens. In addition, density of aromatase-positive cells and concentration of released E2, E3, and free testosterone from superfused synovial tissue was similar in RA and OA but estrogens were markedly higher than free testosterone. In conclusion, ASD and testosterone might be favorable anti-inflammatory compounds because they decrease aromatization and increase anti-inflammatory 5α-reduced androgens. In contrast, DHEA did not block aromatization but yielded high levels of estrogens and proproliferative 16α-hydroxylated steroids. Androgens were differentially converted to pro- and anti-inflammatory steroid hormones via diverse pathways.
format Text
id pubmed-1257423
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-12574232005-10-19 Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens Schmidt, Martin Weidler, Claudia Naumann, Heidrun Anders, Sven Schölmerich, Jürgen Straub, Rainer H Arthritis Res Ther Research Article In synovial cells of patients with osteoarthritis (OA) and rheumatoid arthritis (RA), conversion products of major anti-inflammatory androgens are as yet unknown but may be proinflammatory. Therefore, therapy with androgens in RA could be a problem. This study was carried out in order to compare conversion products of androgens in RA and OA synoviocytes. In 26 OA and 24 RA patients, androgen conversion in synovial cells was investigated using radiolabeled substrates and analysis by thin-layer chromatography and HPLC. Aromatase expression was studied by immunohistochemistry. Dehydroepiandrosterone (DHEA) was converted into androstenediol, androstenedione (ASD), 16αOH-DHEA, 7αOH-DHEA, testosterone, estrone (E1), estradiol (E2), estriol (E3), and 16αOH-testosterone (similar in OA and RA). Surprisingly, levels of E2, E3, and 16α-hydroxylated steroids were as high as levels of testosterone. In RA and OA, 5α-dihydrotestosterone increased conversion of DHEA into testosterone but not into estrogens. The second androgen, ASD, was converted into 5α-dihydro-ASD, testosterone, and negligible amounts of E1, E2, E3, or 16αOH-testosterone. 5α-dihydro-ASD levels were higher in RA than OA. The third androgen, testosterone, was converted into ASD, 5α-dihydro-ASD, 5α-dihydrotestosterone, and negligible quantities of E1 and E2. 5α-dihydrotestosterone was higher in RA than OA. ASD and testosterone nearly completely blocked aromatization of androgens. In addition, density of aromatase-positive cells and concentration of released E2, E3, and free testosterone from superfused synovial tissue was similar in RA and OA but estrogens were markedly higher than free testosterone. In conclusion, ASD and testosterone might be favorable anti-inflammatory compounds because they decrease aromatization and increase anti-inflammatory 5α-reduced androgens. In contrast, DHEA did not block aromatization but yielded high levels of estrogens and proproliferative 16α-hydroxylated steroids. Androgens were differentially converted to pro- and anti-inflammatory steroid hormones via diverse pathways. BioMed Central 2005 2005-06-10 /pmc/articles/PMC1257423/ /pubmed/16207335 http://dx.doi.org/10.1186/ar1769 Text en Copyright © 2005 Schmidt et al.; licensee BioMed Central Ltd.
spellingShingle Research Article
Schmidt, Martin
Weidler, Claudia
Naumann, Heidrun
Anders, Sven
Schölmerich, Jürgen
Straub, Rainer H
Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens
title Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens
title_full Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens
title_fullStr Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens
title_full_unstemmed Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens
title_short Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens
title_sort androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes – androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5α-reduced androgens
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257423/
https://www.ncbi.nlm.nih.gov/pubmed/16207335
http://dx.doi.org/10.1186/ar1769
work_keys_str_mv AT schmidtmartin androgenconversioninosteoarthritisandrheumatoidarthritissynoviocytesandrostenedioneandtestosteroneinhibitestrogenformationandfavorproductionofmorepotent5areducedandrogens
AT weidlerclaudia androgenconversioninosteoarthritisandrheumatoidarthritissynoviocytesandrostenedioneandtestosteroneinhibitestrogenformationandfavorproductionofmorepotent5areducedandrogens
AT naumannheidrun androgenconversioninosteoarthritisandrheumatoidarthritissynoviocytesandrostenedioneandtestosteroneinhibitestrogenformationandfavorproductionofmorepotent5areducedandrogens
AT anderssven androgenconversioninosteoarthritisandrheumatoidarthritissynoviocytesandrostenedioneandtestosteroneinhibitestrogenformationandfavorproductionofmorepotent5areducedandrogens
AT scholmerichjurgen androgenconversioninosteoarthritisandrheumatoidarthritissynoviocytesandrostenedioneandtestosteroneinhibitestrogenformationandfavorproductionofmorepotent5areducedandrogens
AT straubrainerh androgenconversioninosteoarthritisandrheumatoidarthritissynoviocytesandrostenedioneandtestosteroneinhibitestrogenformationandfavorproductionofmorepotent5areducedandrogens